# Treatment of Post-SCI Hypotension

> **NCT02919917** · PHASE2,PHASE3 · COMPLETED · sponsor: **James J. Peters Veterans Affairs Medical Center** · enrollment: 66 (actual)

## Conditions studied

- Spinal Cord Injury
- Autonomic Dysreflexia
- Orthostatic Hypotension
- Baroreceptor Integrity
- Sympathetic Integrity
- Vagal Integrity
- Hypotension
- Cerebral Blood Flow
- Blood Pressure
- Venous Occlusion Plethysmography

## Interventions

- **DRUG:** Midodrine Hydrochloride
- **DRUG:** Midodrine Hydrochloride

## Key facts

- **NCT ID:** NCT02919917
- **Lead sponsor:** James J. Peters Veterans Affairs Medical Center
- **Sponsor class:** FED
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-01
- **Primary completion:** 2021-09-01
- **Final completion:** 2021-09-01
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2025-02-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02919917

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02919917, "Treatment of Post-SCI Hypotension". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02919917. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*